<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; lifeline</title>
	<atom:link href="http://www.tapanray.in/tag/lifeline/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Indian Pharma Marketing’s AI Moment: Lead the Change or Fall Behind</title>
		<link>http://www.tapanray.in/indian-pharma-marketings-ai-moment-lead-the-change-or-fall-behind/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=indian-pharma-marketings-ai-moment-lead-the-change-or-fall-behind</link>
		<comments>http://www.tapanray.in/indian-pharma-marketings-ai-moment-lead-the-change-or-fall-behind/#comments</comments>
		<pubDate>Fri, 23 May 2025 00:00:20 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[adoption]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Artificial]]></category>
		<category><![CDATA[behind]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[Checklist]]></category>
		<category><![CDATA[fall]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[identities]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[Intelligence]]></category>
		<category><![CDATA[Lead]]></category>
		<category><![CDATA[leaders]]></category>
		<category><![CDATA[lifeline]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[moment]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[ROI]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10899</guid>
		<description><![CDATA[(With An Actionable AI Adoption Checklist below for Indian Pharma Marketers) India’s pharmaceutical market is one of the most complex and exciting in the world. With over 60,000 brands battling for attention, millions of patients, and a healthcare landscape rapidly evolving, &#8230; <a href="http://www.tapanray.in/indian-pharma-marketings-ai-moment-lead-the-change-or-fall-behind/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/indian-pharma-marketings-ai-moment-lead-the-change-or-fall-behind/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To reap rich harvest from emerging global opportunities, Indian Biotech sector needs a ‘lifeline’ from the new Government&#8230; Now.</title>
		<link>http://www.tapanray.in/to-reap-rich-harvest-from-emerging-global-opportunities-indian-biotech-sector-needs-a-lifeline-from-the-new-government-now/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-reap-rich-harvest-from-emerging-global-opportunities-indian-biotech-sector-needs-a-lifeline-from-the-new-government-now</link>
		<comments>http://www.tapanray.in/to-reap-rich-harvest-from-emerging-global-opportunities-indian-biotech-sector-needs-a-lifeline-from-the-new-government-now/#comments</comments>
		<pubDate>Thu, 21 May 2009 00:00:27 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[emerging]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[harvest]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[lifeline]]></category>
		<category><![CDATA[needs]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[opportunities]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reap]]></category>
		<category><![CDATA[rich]]></category>
		<category><![CDATA[sector]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=881</guid>
		<description><![CDATA[Growth of Biotech Industry in India took a dip in 2008. It registered a turnover of U.S $2.56 billionwith a growth of 20%, over the previous year. The industry was clocking an annual growth of over 30%, before this period.According &#8230; <a href="http://www.tapanray.in/to-reap-rich-harvest-from-emerging-global-opportunities-indian-biotech-sector-needs-a-lifeline-from-the-new-government-now/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-reap-rich-harvest-from-emerging-global-opportunities-indian-biotech-sector-needs-a-lifeline-from-the-new-government-now/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
